GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
279 hedge funds and large institutions have $2.41B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 88 increasing their positions, 63 reducing their positions, and 53 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 63
7% less funds holding
Funds holding: 299 → 279 (-20)
15% less call options, than puts
Call options by funds: $92.7M | Put options by funds: $109M
22% less capital invested
Capital invested by funds: $3.08B → $2.41B (-$668M)
34% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 53
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$102M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$36.8M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$24.6M |
| 4 |
Jennison Associates
New York
|
+$18M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$85.3M |
| 2 |
FAM
Fred Alger Management
New York
|
-$83.6M |
| 3 |
BlackRock
New York
|
-$22.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$19.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$14.3M |
GWPH Hedge Fund Activity: Q3 2020 in Review
279 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2020, worth a combined $2.41B — down 22% from $3.08B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of GWPH and 35 opened new positions — a net loss of 18 holders — while 63 trimmed existing stakes and 88 added.
The largest buyer was Capital World Investors, adding an estimated $102M. The largest seller was Citadel Advisors, cutting an estimated $85.3M.
- 279 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2020, down from 299 in Q2 2020.
- Funds reported $2.41B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2020, down 22% quarter-over-quarter.
- 35 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2020 and 53 closed out, a net change of -18 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2020 was Capital World Investors, an estimated $102M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2020 was Citadel Advisors, an estimated $85.3M sold.
Based on aggregated 13F filings for Q3 2020.